DATATRAK International, Inc. : DATATRAK Announces Release of Innovative CTMS Product

Extending DATATRAK ONE™, the Unified Software Suite, with Cloud-based uCTMS

CLEVELAND, [January 9th] /PRNewswire/ - DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the release of its new product, uCTMS. As a unified product within the DATATRAK ONE™ suite, this release positions DATATRAK's uCTMS as the most comprehensive unified Clinical Trial Management System in the cloud.

"The new release of our CTMS product improves visibility for executive management and gives clinical operations teams more control of their pipeline, especially when leveraging collaborative partnerships," stated Laurence P. Birch, DATATRAK's Chairman and CEO. "It is exciting to have the uCTMS product as part of our DATATRAK ONE™ clinical research platform that assists customers with the strategy, planning and management of their entire product portfolio."

uCTMS allows for the management of the large amount of data involved during a clinical trial - from the planning stages of the trial all the way to its completion. Specifically:

• Collect data and manage documents
• Report on trial activities from planning and monitoring to expense tracking and study budgets
• Utilize standard dashboards and reports to summarize study metrics in both table and graphic formats
• Report across multiple trials

uCTMS provides the tools necessary for study teams, sponsors or outsource partners to manage both their individual studies and their data in real time, while allowing trial administrators and executives to have a global role-based view of all studies.

About DATATRAK

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit .

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly
report filed with the OTCQX Market announcing its results for the three-month period ending September 30, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

CONTACT:
Lisa Pahl, Director Marketing, DATATRAK International, Inc., [phone]